Frontiers in Anti-Cancer Drug Discovery: Challenges and Perspectives of Metformin as Anti-Angiogenic Add-On Therapy in Glioblastoma

SIMPLE SUMMARY: Glioblastoma is the most aggressive primary brain tumor, with the highest incidence and the worst prognosis. Life expectancy from diagnosis remains dismal, at around 15 months, despite surgical resection and treatment with radiotherapy and chemotherapy. Given the aggressiveness of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Guarnaccia, Laura, Marfia, Giovanni, Masseroli, Matteo Maria, Navone, Stefania Elena, Balsamo, Melissa, Caroli, Manuela, Valtorta, Silvia, Moresco, Rosa Maria, Campanella, Rolando, Garzia, Emanuele, Riboni, Laura, Locatelli, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749852/
https://www.ncbi.nlm.nih.gov/pubmed/35008275
http://dx.doi.org/10.3390/cancers14010112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749852/
https://www.ncbi.nlm.nih.gov/pubmed/35008275
http://dx.doi.org/10.3390/cancers14010112

Ejemplares similares